ZIRGAN - 24208-535-32 - (ganciclovir)

Alphabetical Index


Drug Information of ZIRGAN

Product NDC: 24208-535
Proprietary Name: ZIRGAN
Non Proprietary Name: ganciclovir
Active Ingredient(s): 1.5    mg/g & nbsp;   ganciclovir
Administration Route(s): OPHTHALMIC
Dosage Form(s): GEL
Coding System: National Drug Codes(NDC)

Labeler Information of ZIRGAN

Product NDC: 24208-535
Labeler Name: Bausch & Lomb Incorporated
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA022211
Marketing Category: NDA
Start Marketing Date: 20100430

Package Information of ZIRGAN

Package NDC: 24208-535-32
Package Description: 1 TUBE, WITH APPLICATOR in 1 CARTON (24208-535-32) > 1 g in 1 TUBE, WITH APPLICATOR

NDC Information of ZIRGAN

NDC Code 24208-535-32
Proprietary Name ZIRGAN
Package Description 1 TUBE, WITH APPLICATOR in 1 CARTON (24208-535-32) > 1 g in 1 TUBE, WITH APPLICATOR
Product NDC 24208-535
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name ganciclovir
Dosage Form Name GEL
Route Name OPHTHALMIC
Start Marketing Date 20100430
Marketing Category Name NDA
Labeler Name Bausch & Lomb Incorporated
Substance Name GANCICLOVIR
Strength Number 1.5
Strength Unit mg/g
Pharmaceutical Classes Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC]

Complete Information of ZIRGAN


General Information